FDA Grants Moderna's COVID-19 Vaccine Full Approval

FDA Grants Moderna's COVID-19 Vaccine Full Approval

FDA Grants Moderna's, COVID-19 Vaccine , Full Approval.

On January 31, Moderna announced that its COVID-19 vaccine has been granted full approval by United States health regulators.

.

On January 31, Moderna announced that its COVID-19 vaccine has been granted full approval by United States health regulators.

.

The Associated Press reports that since its emergency authorization over a year ago, the vaccine has already been given to tens of millions of Americans.

.

The Associated Press reports that since its emergency authorization over a year ago, the vaccine has already been given to tens of millions of Americans.

.

In August of 2021, the FDA granted full approval to Pfizer's vaccine.

The Associated Press reports that over 211 million Americans are fully vaccinated - about 63% of the population.

.

The Associated Press reports that over 211 million Americans are fully vaccinated - about 63% of the population.

.

Approximately 86 million people have received at least one dose of a booster.

.

According to the AP, vaccinations peaked at over 3 million doses were distributed per day last spring.

Now, daily doses average less than 750,000.

.

The AP reports that the vaccine's initial emergency approval was based on a study that tracked 44,000 people for two months.

Moderna then continued that study to complete longer six-month-long studies normally required for full approval.

.

The FDA reportedly monitored for serious side effects that have proven to be extremely rare.

.

The FDA reportedly monitored for serious side effects that have proven to be extremely rare.

.

Last fall, the FDA delayed approving Moderna's vaccine for use in 12 to 17 year olds as it investigated the risk of heart inflammation in young men.

.

Last fall, the FDA delayed approving Moderna's vaccine for use in 12 to 17 year olds as it investigated the risk of heart inflammation in young men.